{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:57:29Z","timestamp":1791583049565,"version":"4.3.4"},"reference-count":93,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2017,1,26]]},"DOI":"10.18632\/aging.101158","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T22:07:13Z","timestamp":1485468433000},"page":"256-285","source":"Crossref","is-referenced-by-count":88,"title":["Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures"],"prefix":"10.18632","volume":"9","author":[{"given":"Sifat","family":"Maria","sequence":"first","affiliation":[{"name":"Division of Pharmaceutical Sciences, Duquesne University School of Pharmacy, Pittsburgh, PA 15282, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Swanson","sequence":"additional","affiliation":[{"name":"Functional Medicine, Heart Preventics, LLC, Sequim, WA 98382, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry T.","family":"Enderby","sequence":"additional","affiliation":[{"name":"Enderby Healthcare\/Legal Consulting, LLC, Pittsburgh, PA 15102, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Department of Mathematics, Duquesne University School of Liberal Arts, Pittsburgh, PA 15282, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Enderby","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutical Sciences, Duquesne University School of Pharmacy, Pittsburgh, PA 15282, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah M.","family":"Samsonraj","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Department of Orthopedic Surgery, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Dudakovic","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Department of Orthopedic Surgery, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre J.","family":"van Wijnen","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Department of Orthopedic Surgery, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Witt-Enderby","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutical Sciences, Duquesne University School of Pharmacy, Pittsburgh, PA 15282, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,1,26]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/jpi.12116","article-title":"Melatonin effects on bone: potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bone-grafting procedures.","volume":"5","author":"Witt-Enderby","year":"2014","journal-title":"J Pineal Res"},{"key":"2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cger.2014.01.009","article-title":"Secondary prevention after an osteoporosis-related fracture: an overview.","volume":"3","author":"Bogoch","year":"2014","journal-title":"Clin Geriatr Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.14423\/SMJ.0000000000000410","article-title":"Changes in Nonosteoporotic Bone Density and Subsequent Fractures in Women.","volume":"10","author":"Emmett","year":"2016","journal-title":"South Med J"},{"key":"4","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1007\/s00198-006-0135-9","article-title":"The population burden of fractures originates in women with osteopenia, not osteoporosis.","volume":"1","author":"Kotowicz","year":"2006","journal-title":"Osteoporos Int"},{"key":"5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/gme.0b013e3181a3cdaf","article-title":"Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women\u2019s Health Across the Nation.","volume":"1","author":"Schocken","year":"2009","journal-title":"Menopause"},{"key":"6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jocd.2008.04.003","article-title":"National Osteoporosis Foundation 2008 Clinician\u2019s Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist.","volume":"1","author":"Baim","year":"2008","journal-title":"J Clin Densitom"},{"key":"7","first-page":"CD000227","article-title":"Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.","author":"O\u2019Connell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"8","doi-asserted-by":"publisher","first-page":"h4580","DOI":"10.1136\/bmj.h4580","article-title":"Calcium intake and risk of fracture: systematic review.","volume":"35","author":"Reid","year":"2015","journal-title":"BMJ"},{"key":"9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1749-6632.2010.05666.x","article-title":"Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis.","volume":"120","author":"Zafeiris","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","article-title":"Bone mineral density thresholds for pharmacological intervention to prevent fractures.","volume":"16","author":"Berger","year":"2004","journal-title":"Arch Intern Med"},{"key":"11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1600-079X.2011.00956.x","article-title":"Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women.","volume":"5","author":"Balk","year":"2012","journal-title":"J Pineal Res"},{"key":"12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/jpi.12252","article-title":"Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial.","volume":"5","author":"Rejnmark","year":"2015","journal-title":"J Pineal Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.","volume":"9","author":"Meunier","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.","volume":"35","author":"Reginster","year":"2004","journal-title":"N Engl J Med"},{"key":"15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1753-4887.2006.tb00184.x","article-title":"Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis.","volume":"6","author":"Sato","year":"2006","journal-title":"Nutr Rev"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Sato T. Vitamin K2 and bone quality. Vitam Trace Elem. 2013; S6:001.","DOI":"10.4172\/2167-0390.S6-001"},{"key":"17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00223-012-9571-z","article-title":"Changes in parameters of bone metabolism in postmenopausal women following a 12-month intervention period using dairy products enriched with calcium, vitamin D, and phylloquinone (vitamin K(1)) or menaquinone-7 (vitamin K (2)): the Postmenopausal Health Study II.","volume":"9","author":"Manios","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0378-5122(01)00275-4","article-title":"Effect of continuous combined therapy with vitamin K(2) and vitamin D(3) on bone mineral density and coagulofibrinolysis function in postmenopausal women.","volume":"4","author":"Ueki","year":"2002","journal-title":"Maturitas"},{"key":"19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s40618-015-0299-2","article-title":"Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate.","volume":"3","author":"Lasco","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"20","doi-asserted-by":"publisher","first-page":"354151","DOI":"10.1155\/2012\/354151","article-title":"Combination of Micronutrients for Bone (COMB) Study: bone density after micronutrient intervention.","volume":"201","author":"Bouchard","year":"2012","journal-title":"J Environ Public Health"},{"key":"21","first-page":"132","article-title":"An Early Development Budget Impact Model for the use of Melatonin in the Treatment and Prevention of Osteoporosis.","volume":"4","author":"Witt-Enderby","year":"2015","journal-title":"Clin Pharmacol Biopharm"},{"key":"22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.abb.2008.03.027","article-title":"Osteoclast-osteoblast communication.","volume":"47","author":"Irie","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"23","doi-asserted-by":"publisher","first-page":"487463","DOI":"10.1155\/2014\/487463","article-title":"Serum 25-OH Vitamin D in relation to bone mineral density and bone turnover.","volume":"201","author":"Carmina","year":"2014","journal-title":"Int J Endocrinol"},{"key":"24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bone.2014.03.047","article-title":"Associations among endocrine, inflammatory, and bone markers, body composition and weight loss induced bone loss.","volume":"6","author":"Van Loan","year":"2014","journal-title":"Bone"},{"key":"25","first-page":"499","article-title":"Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.","volume":"5","author":"V\u00e4\u00e4n\u00e4nen","year":"2006","journal-title":"Clin Lab"},{"key":"26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1359\/jbmr.2000.15.1.103","article-title":"Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover.","volume":"1","author":"Hume","year":"2000","journal-title":"J Bone Miner Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","article-title":"Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.","volume":"27","author":"Sakai","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"28","doi-asserted-by":"publisher","first-page":"36846","DOI":"10.1074\/jbc.M606656200","article-title":"Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand.","volume":"28","author":"Tanaka","year":"2006","journal-title":"J Biol Chem"},{"key":"29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1600-079X.2006.00318.x","article-title":"Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK\/ERK (1\/2) signaling cascade.","volume":"4","author":"Witt-Enderby","year":"2006","journal-title":"J Pineal Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1128\/MCB.01549-08","article-title":"Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis.","volume":"2","author":"Murakami","year":"2009","journal-title":"Mol Cell Biol"},{"key":"31","doi-asserted-by":"publisher","first-page":"32533","DOI":"10.1074\/jbc.M109.040980","article-title":"Identification and functional characterization of extracellular-regulated kinase\/MAPK phosphorylation sites in the Runx2 transcription factor.","volume":"28","author":"Franceschi","year":"2009","journal-title":"J Biol Chem"},{"key":"32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1083\/jcb.200610046","article-title":"Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development.","volume":"17","author":"Franceschi","year":"2007","journal-title":"J Cell Biol"},{"key":"33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1600-079X.2010.00784.x","article-title":"Determination of the minimal melatonin exposure required to induce osteoblast differentiation from human mesenchymal stem cells and these effects on downstream signaling pathways.","volume":"4","author":"Witt-Enderby","year":"2010","journal-title":"J Pineal Res"},{"key":"34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/03008207.2016.1181063","article-title":"Fluid shear stress promotes osteoblast proliferation via the G\u03b1q-ERK5 signaling pathway.","volume":"5","author":"Yayi","year":"2016","journal-title":"Connect Tissue Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bbrc.2015.05.035","article-title":"MEK5 suppresses osteoblastic differentiation.","volume":"46","author":"Higuchi","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11010-012-1233-y","article-title":"Cyclic fluid shear stress promotes osteoblastic cells proliferation through ERK5 signaling pathway.","volume":"36","author":"Xia","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"37","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1359\/jbmr.2002.17.7.1219","article-title":"Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation.","volume":"1","author":"Lau","year":"2002","journal-title":"J Bone Miner Res"},{"key":"38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1600-079X.2012.01007.x","article-title":"Effects on bone by the light\/dark cycle and chronic treatment with melatonin and\/or hormone replacement therapy in intact female mice.","volume":"5","author":"Davis","year":"2012","journal-title":"J Pineal Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-4652(200008)184:2<207::AID-JCP8>3.0.CO;2-U","article-title":"Type I collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagen-\u03b12\u03b21 integrin interaction.","volume":"18","author":"Kuboki","year":"2000","journal-title":"J Cell Physiol"},{"key":"40","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nm1054","article-title":"Selective inhibition of NF-\u03ba B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.","volume":"1","author":"Ghosh","year":"2004","journal-title":"Nat Med"},{"key":"41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling.","volume":"47","author":"Xing","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL-RANK signaling in osteoclastogenesis and bone disease.","volume":"1","author":"Penninger","year":"2006","journal-title":"Trends Mol Med"},{"key":"43","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nm.1954","article-title":"Inhibition of osteoblastic bone formation by nuclear factor-kappaB.","volume":"1","author":"Wang","year":"2009","journal-title":"Nat Med"},{"key":"44","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00018-014-1801-2","article-title":"Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.","volume":"7","author":"Marie","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"45","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1172\/JCI200419900","article-title":"PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.","volume":"11","author":"Kawaguchi","year":"2004","journal-title":"J Clin Invest"},{"key":"46","first-page":"1044","article-title":"Expression of glucose transporter-4 by the osteoblast is required for global glucose metabolism.","volume":"2","author":"Clemens","year":"2013","journal-title":"J Bone Miner Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1196\/annals.1402.034","article-title":"Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts.","volume":"111","author":"Kato","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","article-title":"Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism.","volume":"14","author":"Karsenty","year":"2010","journal-title":"Cell"},{"key":"49","first-page":"27604","article-title":"Epigenetic control of skeletal development by the histone methyltransferase Ezh2.","volume":"29","author":"Dietz","year":"2015","journal-title":"J Biol Chem"},{"key":"50","doi-asserted-by":"publisher","first-page":"24594","DOI":"10.1074\/jbc.M116.740571","article-title":"Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice.","volume":"29","author":"Montecino","year":"2016","journal-title":"J Biol Chem"},{"key":"51","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1210\/jc.2007-1876","article-title":"Bone mineral density changes during the menopause transition in a multiethnic cohort of women.","volume":"9","author":"Neer","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"52","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.2215\/CJN.04151206","article-title":"Normal bone anatomy and physiology.","volume":"3","author":"Clarke","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"53","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/cen.12942","article-title":"Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo-controlled trial.","volume":"8","author":"Rejnmark","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"54","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/jcb.10369","article-title":"Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways.","volume":"8","author":"Xiao","year":"2003","journal-title":"J Cell Biochem"},{"key":"55","doi-asserted-by":"publisher","first-page":"33132","DOI":"10.1074\/jbc.M500608200","article-title":"Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression.","volume":"28","author":"Lian","year":"2005","journal-title":"J Biol Chem"},{"key":"56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fcell.2016.00040","article-title":"p38 MAPK Signaling in Osteoblast Differentiation.","volume":"4","author":"Ventura","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"57","unstructured":"Sims NA, Gooi JH. (2008). Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol: Elsevier), pp. 444-451."},{"key":"58","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11154-010-9153-1","article-title":"Cellular mechanisms of bone remodeling.","volume":"1","author":"Eriksen","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"59","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bone.2009.03.671","article-title":"Local communication on and within bone controls bone remodeling.","volume":"4","author":"Karsdal","year":"2009","journal-title":"Bone"},{"key":"60","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11154-010-9138-0","article-title":"Compliance and persistence with osteoporosis medications: a critical review of the literature.","volume":"1","author":"Gold","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"61","doi-asserted-by":"publisher","first-page":"iv20","DOI":"10.1093\/rheumatology\/ken166","article-title":"Strontium ranelate: short- and long-term benefits for post-menopausal women with osteoporosis.","volume":"4","author":"Roux","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"62","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1210\/jc.2013-3629","article-title":"Associations between sleep duration, daytime nap duration, and osteoporosis vary by sex, menopause, and sleep quality.","volume":"9","author":"Gong","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"63","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1600-079X.2006.00369.x","article-title":"Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy.","volume":"4","author":"Davis","year":"2006","journal-title":"J Pineal Res"},{"key":"64","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0531-5565(00)00217-5","article-title":"Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study.","volume":"3","author":"Ilyia","year":"2001","journal-title":"Exp Gerontol"},{"key":"65","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJM199704033361418","article-title":"Variable bioavailability of oral melatonin.","volume":"33","author":"Silman","year":"1997","journal-title":"N Engl J Med"},{"key":"66","doi-asserted-by":"publisher","first-page":"9694","DOI":"10.1007\/s11357-014-9694-4","article-title":"Relationship between vitamin D and inflammatory markers in older individuals.","volume":"3","author":"Maggio","year":"2014","journal-title":"Age (Dordr)"},{"key":"67","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/art.34474","article-title":"Association between bone mineral density and C-reactive protein in a large population-based sample.","volume":"6","author":"Buckley","year":"2012","journal-title":"Arthritis Rheum"},{"key":"68","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4162\/nrp.2011.5.2.150","article-title":"Relationship between inflammation biomarkers, antioxidant vitamins, and bone mineral density in patients with metabolic syndrome.","volume":"5","author":"Sohn","year":"2011","journal-title":"Nutr Res Pract"},{"key":"69","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00198-005-1840-5","article-title":"Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis.","volume":"1","author":"Kim","year":"2005","journal-title":"Osteoporos Int"},{"key":"70","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/jbmr.1915","article-title":"C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women\u2019s Health Across the Nation (SWAN).","volume":"2","author":"Karlamangla","year":"2013","journal-title":"J Bone Miner Res"},{"key":"71","doi-asserted-by":"publisher","first-page":"e53381","DOI":"10.1371\/journal.pone.0053381","article-title":"Seasonal variation in 25(OH)D at Aberdeen (57\u00b0N) and bone health indicators--could holidays in the sun and cod liver oil supplements alleviate deficiency?","volume":"8","author":"Macdonald","year":"2013","journal-title":"PLoS One"},{"key":"72","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1002\/jbmr.2232","article-title":"Impacts of body mass index, physical activity, and smoking on femoral bone loss: the Troms\u00f8 study.","volume":"2","author":"Ahmed","year":"2014","journal-title":"J Bone Miner Res"},{"key":"73","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11914-010-0027-y","article-title":"Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis.","volume":"8","author":"Lecka-Czernik","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"74","doi-asserted-by":"publisher","first-page":"27489","DOI":"10.1155\/PPAR\/2006\/27489","article-title":"Resolving the two \u201cbony\u201d faces of PPAR-\u03b3.","volume":"200","author":"Suva","year":"2006","journal-title":"PPAR Res"},{"key":"75","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1600-079X.2010.00803.x","article-title":"Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPAR\u03b3 expression and enhancing Runx2 expression.","volume":"4","author":"Huang","year":"2010","journal-title":"J Pineal Res"},{"key":"76","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1474-9726.2012.00804.x","article-title":"Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc\/Maf and Wnt signaling.","volume":"1","author":"Marie","year":"2012","journal-title":"Aging Cell"},{"key":"77","doi-asserted-by":"publisher","first-page":"E219","DOI":"10.1152\/ajpendo.00695.2006","article-title":"Suppression of PPAR-\u03b3 attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes.","volume":"29","author":"Olefsky","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"78","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.tem.2007.02.001","article-title":"Transcriptional regulation of the GLUT4 gene: from PPAR-\u03b3 and FOXO1 to FFA and inflammation.","volume":"1","author":"Karnieli","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"79","doi-asserted-by":"publisher","first-page":"S407","DOI":"10.1007\/s00198-010-1253-y","article-title":"Development and use of FRAX in osteoporosis.","volume":"2","author":"Borgstr\u00f6m","year":"2010","journal-title":"Osteoporos Int"},{"key":"80","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s00198-011-1713-z","article-title":"Interpretation and use of FRAX in clinical practice.","volume":"2","author":"Lewiecki","year":"2011","journal-title":"Osteoporos Int"},{"key":"81","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.maturitas.2004.06.015","article-title":"Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire.","volume":"5","author":"Wong","year":"2005","journal-title":"Maturitas"},{"key":"82","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.maturitas.2008.09.014","article-title":"A menopause-specific quality of life questionnaire: development and psychometric properties.","volume":"6","author":"Dunn","year":"2008","journal-title":"Maturitas"},{"key":"83","unstructured":"Spielberger CD, Gorsuch RL, Lushene R. The state-trait anxiety inventory: A Test Manual. Consulting Psychologists press, Palo Alto, CA. 1970; 22."},{"key":"84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/psych.2010.11001","article-title":"Psychometric evaluation of the perceived stress scale in early postmenopausal Chinese women.","volume":"1","author":"Ho","year":"2010","journal-title":"Psychology (Irvine)"},{"key":"85","unstructured":"Cohen S, Williamson GM. Perceived stress in a probability sample of the United States. In The Social Psychology of Health (Eds:  S. Spacapan and S. Oskamp). Newbury Park, CA, 1988."},{"key":"86","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress.","volume":"2","author":"Mermelstein","year":"1983","journal-title":"J Health Soc Behav"},{"key":"87","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale a self-report depression scale for research in the general population.","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl Psychol Meas"},{"key":"88","unstructured":"American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription: Lippincott Williams & Wilkins. 2013."},{"key":"89","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/scrt328","article-title":"Effects of dexamethasone, ascorbic acid and \u03b2-glycerophosphate on the osteogenic differentiation of stem cells in vitro.","volume":"4","author":"Handschel","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"90","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1359\/jbmr.2003.18.6.1088","article-title":"RANKL expression is related to the differentiation state of human osteoblasts.","volume":"1","author":"Zannettino","year":"2003","journal-title":"J Bone Miner Res"},{"key":"91","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1359\/jbmr.2001.16.4.788","article-title":"Naphthol-ASBI phosphate as a preferred substrate for tartrate-resistant acid phosphatase isoform 5b.","volume":"1","author":"Yam","year":"2001","journal-title":"J Bone Miner Res"},{"key":"92","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3727\/096368910X543376","article-title":"Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability.","volume":"2","author":"Terzic","year":"2011","journal-title":"Cell Transplant"},{"key":"93","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1473-3099(13)70033-1","article-title":"Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial.","volume":"1","author":"Jacobson","year":"2013","journal-title":"Lancet Infect Dis"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T12:35:38Z","timestamp":1599050138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1,31]]}},"alternative-id":["101158","28130552"],"URL":"https:\/\/doi.org\/10.18632\/aging.101158","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,26]]}}}